tiprankstipranks
Trending News
More News >
Oryzon Genomics SA (DE:ORN)
FRANKFURT:ORN
Germany Market

Oryzon Genomics SA (ORN) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

ORN Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Oryzon
Genomics SA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ORN Stock 12 Month Forecast

There Are No Analyst Ratings for DE:ORN In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ORN Financial Forecast

ORN Earnings Forecast

Next quarter’s earnings estimate for ORN is -€0.03 with a range of -€0.03 to -€0.03. The previous quarter’s EPS was >-€0.01. ORN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ORN has Performed in-line its overall industry.
Next quarter’s earnings estimate for ORN is -€0.03 with a range of -€0.03 to -€0.03. The previous quarter’s EPS was >-€0.01. ORN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ORN has Performed in-line its overall industry.
No data currently available

ORN Sales Forecast

Next quarter’s sales forecast for ORN is €1.90M with a range of €0.00 to €3.80M. The previous quarter’s sales results were €0.00. ORN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year ORN has Performed in-line its overall industry.
Next quarter’s sales forecast for ORN is €1.90M with a range of €0.00 to €3.80M. The previous quarter’s sales results were €0.00. ORN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year ORN has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Roth MKM Analyst forecast on DE:ORN
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
€12
Buy
294.74%
Upside
Reiterated
11/04/25
Oryzon Genomics SA (ORN) Gets a Buy from Roth MKM
Jefferies
€4
Buy
31.58%
Upside
Reiterated
03/25/25
Jefferies Sticks to Their Buy Rating for Oryzon Genomics SA (ORN)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Roth MKM Analyst forecast on DE:ORN
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
€12
Buy
294.74%
Upside
Reiterated
11/04/25
Oryzon Genomics SA (ORN) Gets a Buy from Roth MKM
Jefferies
€4
Buy
31.58%
Upside
Reiterated
03/25/25
Jefferies Sticks to Their Buy Rating for Oryzon Genomics SA (ORN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Oryzon Genomics SA

3 Months
xxx
Success Rate
0/3 ratings generated profit
0%
Average Return
-10.67%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -10.67% per trade.
1 Year
Success Rate
3/3 ratings generated profit
100%
Average Return
+32.83%
reiterated a buy rating 11 months ago
Copying Lucy Codrington's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +32.83% per trade.
2 Years
xxx
Success Rate
3/3 ratings generated profit
100%
Average Return
+42.27%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +42.27% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ORN Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Nov 25
Jan 26
Feb 26
Strong Buy
1
1
1
1
1
Buy
0
0
0
0
0
Hold
9
13
10
54
60
Sell
0
1
1
13
15
Strong Sell
0
0
0
0
0
total
10
15
12
68
76
In the current month, ORN has received 1 Buy Ratings, 60 Hold Ratings, and 15 Sell Ratings. ORN average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

ORN Stock Forecast FAQ

What is DE:ORN’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:ORN’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:ORN, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Oryzon Genomics SA a Buy, Sell or Hold?
      Currently, no data Available
      What is Oryzon Genomics SA’s share price target?
      Currently, no data Available
      What do analysts say about Oryzon Genomics SA?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Oryzon Genomics SA?
      To buy shares of DE:ORN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.